ArticleBMC cancer2020

Evaluation of adverse effects of chemotherapy regimens of 5-fluoropyrimidines derivatives and their association with DPYD polymorphisms in colorectal cancer patients.

Reza Negarandeh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.